Product Images Ciprofloxacin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Ciprofloxacin NDC 68071-4849 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PDP - 68071 4849 2

PDP - 68071 4849 2

NuCare Pharmaceuticals, Inc. sells Ciprofloxacin 500mg tablets in a bottle of 20 tablets. The tablets are oval-shaped, white, and film-coated. Each tablet contains Ciprofloxacin HCI USP equivalent to 500mg of Ciprofloxacin. The lot number is 000000 and the NDC number is 68071-4849-02. The product may increase the risk of developing tendinitis and tendon rupture in patients taking fluoroquinolones for systemic use. The patients are advised to call their doctors for medical advice if side effects occur. The side effects can be reported to the FDA at 1-800-FDA-1088. The drug shouldn't be used by children and should be stored at controlled temperature between 68-77°F.*

83a02505 7395 456b e053 2991aa0a4528

83a02505 7395 456b e053 2991aa0a4528

chemical structure-1 - e82d3489 fb62 4ddd 9e7a 789048877232 1

chemical structure-1 - e82d3489 fb62 4ddd 9e7a 789048877232 1

formulae - formulae

formulae - formulae

This text provides a formula to calculate creatinine clearance for men and women based on weight, age, and serum creatinine levels. For men, the formula is weight (kg) x (140 - age) divided by 72 x serum creatinine (mg/dL). For women, the value calculated for men is multiplied by 0.85.*

chemical structure-2 - structure 2

chemical structure-2 - structure 2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.